International Trade Bulletin - Volume 1, Issue 2
Client Alert | 2 min read | 04.03.06
Inside this issue:
- CALIFORNIA IN THE SPOTLIGHT
- Wine Industry: The United States and the European Union have signed a bilateral wine trade agreement that will facilitate trade but also increase competition in the two wine markets
- Bilateral Trade: On March 8, the Bush Administration announced its latest plan to help U.S. exporters and importers do business in the Asia-Pacific market – a proposed U.S. – Malaysia Free Trade Agreement (FTA)
- EUROPE IN THE SPOTLIGHT
- Chemicals: New EU rules on the Registration, Evaluation and Authorization of Chemicals (REACH) will greatly affect the business reality for a large number of chemical companies as well as downstream users doing business in Europe and elsewhere
- Market Access: The EU and the U.S. are each other’s main trading partners, accounting for the largest bilateral trade relationship in the world
- EU TRADE REMEDIES: European Union Introduces “Flexible” Features into Its Anti-Dumping Measures
- WTO: The US and the EU have come together to request WTO consultations with China on its tariffs on automotive parts signaling an important change in the relationship among the three trading partners
- INVESTMENT: Investors clearly have begun to realize the significance of the rights guaranteed to them under NAFTA and other investment treaties, as well as their ability to enforce them
- US TRADE REMEDIES : Two initiatives currently underway in the U.S. government may make the prospects of bringing antidumping actions less attractive to U.S. petitioners
- SANCTIONS: The U.S. extraterritorial sanctions continue to wreak havoc with sourcing for companies worldwide
- CHINA EXPORT ISSUES: China "catch all" export control delayed but not dead; major review of China export policy underway
Insights
Client Alert | 3 min read | 06.30.25
The New EU “Pharma Package”: Preparing for the Trilogues
On June 4, 2025, after nearly two years of intense debate and negotiation between the 27 EU Member States, the Council of the European Union adopted its position on the proposed overhaul of the EU general pharmaceutical legislative framework known as the new Pharma Package.
Client Alert | 3 min read | 06.26.25
FDA Targets Gene Editing Clinical Trials in China and other “Hostile Countries”
Client Alert | 3 min read | 06.26.25
Client Alert | 4 min read | 06.26.25
Ninth Circuit Affirms that CIPA Only Applies to Third-Party Eavesdropping
